Tuesday, January 9, 2018

Limited-completion drugs, which are either complex generic or innovative specialty drugs that require higher spend and command better pricing power

from Companies http://ift.tt/2AK14hV

Related Posts:

  • LATEST BUSINESS NEWSActivist investor Barington Capital has agreed to withdraw its proposed board nominees and instead will serve as a special adviser as part of an agreement with the company. from The Business of Fashion http://bit.ly/2VUuMvX … Read More
  • LATEST BUSINESS NEWSChairman Terry Duddy will take over on an interim basis as the company seeks a successor to Sergio Bucher. from The Business of Fashion http://bit.ly/2Iu6SUU … Read More
  • LATEST BUSINESS NEWSThe group’s chairman and chief executive also addressed criticism around his Notre-Dame donation, and concerns from animal rights activists about LVMH’s use of exotic skins. from The Business of Fashion http://bit.ly/2UGySLL… Read More
  • LATEST BUSINESS NEWSThe French beauty group said on Thursday that Axel Dumas, the CEO of Birkin-bag maker Hermes, had resigned as a board member as the luxury group starts work on its own line of cosmetics. from The Business of Fashion http://b… Read More
  • LATEST BUSINESS NEWSThis week, Hearst UK names Farrah Storr’s replacement at Cosmopolitan, while Xavier Romatet is appointed general manager of IFM. from The Business of Fashion http://bit.ly/2XopqJW … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner